FEMY
Femasys Inc.
Price Chart
Latest Quote
$4.08
+0.04 (+0.99%)
Current Price
| Previous Close | $4.04 |
| Open | $4.02 |
| Day High | $4.45 |
| Day Low | $3.86 |
| Volume | 43,550 |
Stock Information
| Shares Outstanding | 3.02M |
| Total Debt | $4.73M |
| Cash Equivalents | $5.39M |
| Revenue | $2.38M |
| Net Income | $-12.40M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $12.32M |
| EPS (TTM) | $-4.78 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $11.66M |
| Sales | $2.38M |
| Income | $-12.40M |
| Book/sh | $0.12 |
| Cash/sh | $1.78 |
| Employees | 51 |
Financial Ratios
| Quick Ratio | 1.76 |
| Current Ratio | 3.91 |
| Debt/Eq | 64.86 |
Returns & Margins
| ROA | -68.65% |
| ROE | -255.96% |
| Gross Margin | 61.56% |
| Operating Margin | -994.03% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| Forward P/E | -0.70 |
| P/S | 5.18 |
| P/B | 33.72 |
Analyst Data
| Recommendation | none |
| Target Price | $63.33 |
Technical Indicators
| SMA20 | $6.00 |
| SMA50 | $7.14 |
| SMA200 | $10.96 |
| RSI | 10.09 |
| ATR | 0.6552 |
| Shares Float | 2.50M |
| Short Float | 5.77% |
| Short Ratio | 1.76 |
| Volatility | -2.22 |
| Rel Volume | 0.32 |
Performance History
| Week | -2.39% |
| Month | -41.88% |
| Quarter | -63.38% |
| 6 Months | -73.37% |
| YTD | -67.97% |
| Year | -76.82% |
| 3 Years | -68.13% |
| 10 Years | -98.30% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $4.08 | 43,550 |
| 2026-06-18 | $4.04 | 43,800 |
| 2026-06-17 | $4.19 | 59,600 |
| 2026-06-16 | $3.84 | 54,500 |
| 2026-06-15 | $3.98 | 97,400 |
| 2026-06-12 | $4.18 | 89,900 |
| 2026-06-11 | $4.78 | 42,600 |
| 2026-06-10 | $4.73 | 105,500 |
| 2026-06-09 | $5.25 | 70,100 |
| 2026-06-08 | $5.39 | 166,700 |
| 2026-06-05 | $6.12 | 129,725 |
| 2026-06-04 | $7.14 | 52,525 |
| 2026-06-03 | $7.36 | 36,090 |
| 2026-06-02 | $7.42 | 31,700 |
| 2026-06-01 | $7.56 | 42,010 |
| 2026-05-29 | $7.74 | 85,715 |
| 2026-05-28 | $7.60 | 63,610 |
| 2026-05-27 | $7.56 | 127,610 |
| 2026-05-26 | $8.20 | 602,840 |
About Femasys Inc.
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
đ° Latest News
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More
Motley Fool âĸ 2026-05-29T22:55:31Z
BC-Most Active Stocks
Associated Press Finance âĸ 2025-11-03T15:30:18ZFemasys partners with Medical Electronic Systems for FemSperm kit
TipRanks âĸ 2025-09-23T13:20:45Z
Femasys (FEMY) Falls 27% as Firm to Raise $8-Million from Share Sale
Insider Monkey âĸ 2025-08-27T16:02:31Z
Femasys Prices $8 Million Public Offering; Shares Slump Pre-Bell
MT Newswires âĸ 2025-08-26T08:26:59ZFemasys Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. âĸ 2025-08-11T10:50:35Z
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates
Zacks âĸ 2025-08-08T21:15:01Z
Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates
Zacks âĸ 2025-08-07T13:25:01Z
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates
Zacks âĸ 2025-08-06T22:50:02Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $363,978 | $544,903 | $380,069 | $114,031 |
| Cost Of Revenue | $872,400 | $544,903 | $380,069 | $441,938 |
| Total Revenue | $2,293,313 | $1,629,108 | $1,071,970 | $1,206,218 |
| Operating Revenue | $2,293,313 | $1,629,108 | $1,071,970 | $1,206,218 |
| Expenses | ||||
| Interest Expense | $1,891,119 | $1,603,575 | $165,390 | $13,464 |
| Total Expenses | $19,881,982 | $19,414,913 | $15,580,385 | $12,806,482 |
| Other Income Expense | $751,438 | - | - | $-2,306 |
| Other Non Operating Income Expenses | $-482,562 | - | - | $-2,306 |
| Net Non Operating Interest Income Expense | $-1,789,359 | $-1,021,221 | $265,629 | $214,700 |
| Interest Expense Non Operating | $1,891,119 | $1,603,575 | $165,390 | $13,464 |
| Operating Expense | $19,009,582 | $18,870,010 | $15,200,316 | $12,364,544 |
| Selling And Marketing Expense | $4,443,807 | $4,030,150 | $650,126 | $558,852 |
| General And Administrative Expense | $6,646,037 | $6,325,999 | $6,858,008 | $5,430,704 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-18,627,887 | $-18,816,628 | $-14,247,124 | $-11,394,170 |
| Net Interest Income | $-1,789,359 | $-1,021,221 | $265,629 | $214,700 |
| Interest Income | $101,760 | $582,354 | $431,019 | $228,164 |
| Normalized Income | $-19,861,887 | $-18,816,628 | $-14,247,124 | $-11,394,170 |
| Net Income From Continuing And Discontinued Operation | $-18,627,887 | $-18,816,628 | $-14,247,124 | $-11,394,170 |
| Total Operating Income As Reported | $-17,588,669 | $-17,785,805 | $-14,508,415 | $-11,600,264 |
| Net Income Common Stockholders | $-18,627,887 | $-18,816,628 | $-14,247,124 | $-11,394,170 |
| Net Income | $-18,627,887 | $-18,816,628 | $-14,247,124 | $-11,394,170 |
| Net Income Including Noncontrolling Interests | $-18,627,887 | $-18,816,628 | $-14,247,124 | $-11,394,170 |
| Net Income Continuous Operations | $-18,627,887 | $-18,816,628 | $-14,247,124 | $-11,394,170 |
| Pretax Income | $-18,626,590 | $-18,807,026 | $-14,242,786 | $-11,387,870 |
| Interest Income Non Operating | $101,760 | $582,354 | $431,019 | $228,164 |
| Operating Income | $-17,588,669 | $-17,785,805 | $-14,508,415 | $-11,600,264 |
| Depreciation Amortization Depletion Income Statement | $342,034 | $297,318 | $483,481 | $561,233 |
| Depreciation And Amortization In Income Statement | $342,034 | $297,318 | $483,481 | $561,233 |
| Gross Profit | $1,420,913 | $1,084,205 | $691,901 | $764,280 |
| Per Share | ||||
| Diluted EPS | $-9.40 | $-17.00 | $-18.60 | $-19.20 |
| Basic EPS | $-9.40 | $-17.00 | $-18.60 | $-19.20 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-17,119,015 | $-16,331,451 | $-13,169,411 | $-10,485,266 |
| Total Unusual Items | $1,234,000 | - | - | - |
| Total Unusual Items Excluding Goodwill | $1,234,000 | - | - | - |
| Reconciled Depreciation | $850,456 | $872,000 | $907,985 | $889,140 |
| EBITDA (Bullshit earnings) | $-15,885,015 | $-16,331,451 | $-13,169,411 | $-10,485,266 |
| EBIT | $-16,735,471 | $-17,203,451 | $-14,077,396 | $-11,374,406 |
| Diluted Average Shares | $1,977,460 | $1,113,384 | $769,218 | $590,750 |
| Basic Average Shares | $1,977,460 | $1,113,384 | $769,218 | $590,750 |
| Diluted NI Availto Com Stockholders | $-18,627,887 | $-18,816,628 | $-14,247,124 | $-11,394,170 |
| Tax Provision | $1,297 | $9,602 | $4,338 | $6,300 |
| Gain On Sale Of Security | $1,234,000 | - | - | - |
| Research And Development | $7,577,704 | $8,216,543 | $7,208,701 | $5,813,755 |
| Selling General And Administration | $11,089,844 | $10,356,149 | $7,508,134 | $5,989,556 |
| Other Gand A | $6,646,037 | $6,325,999 | $6,858,008 | $5,430,704 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $5,734,388 | $2,238,504 | $18,352,589 | $15,239,225 |
| Total Assets | $20,724,177 | $12,445,002 | $27,755,825 | $16,895,570 |
| Total Non Current Assets | $4,267,842 | $4,422,552 | $4,577,845 | $2,764,079 |
| Other Non Current Assets | $940,232 | $954,992 | $1,086,581 | $958,177 |
| Goodwill And Other Intangible Assets | $134,914 | $65,918 | $0 | $3,294 |
| Current Assets | $16,456,335 | $8,022,450 | $23,177,980 | $14,131,491 |
| Other Current Assets | $833,133 | $1,035,993 | $695,879 | $655,362 |
| Inventory | $5,740,249 | $3,046,323 | $667,118 | $436,723 |
| Receivables | $616,600 | $488,373 | $98,906 | $77,470 |
| Accounts Receivable | $616,600 | $488,373 | $98,906 | $77,470 |
| Allowance For Doubtful Accounts Receivable | $-14,013 | $-10,000 | $-2,000 | $-2,048 |
| Gross Accounts Receivable | $630,613 | $498,373 | $100,906 | $79,518 |
| Cash Cash Equivalents And Short Term Investments | $9,266,353 | $3,451,761 | $21,716,077 | $12,961,936 |
| Cash And Cash Equivalents | $9,266,353 | $3,451,761 | $21,716,077 | $12,961,936 |
| Other Intangible Assets | - | $65,918 | - | $3,294 |
| Cash Equivalents | - | $3,451,761 | - | - |
| Debt | ||||
| Total Debt | $4,696,964 | $7,442,295 | $6,700,882 | $543,715 |
| Long Term Debt And Capital Lease Obligation | $4,209,340 | $1,518,100 | $6,294,246 | $28,584 |
| Long Term Debt | $3,178,864 | - | $4,258,179 | - |
| Current Debt And Capital Lease Obligation | $487,624 | $5,924,195 | $406,636 | $515,131 |
| Net Debt | - | $1,954,467 | - | - |
| Current Debt | - | $5,406,228 | - | $141,298 |
| Other Current Borrowings | - | $5,406,228 | - | $186,504 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $14,854,875 | $10,140,580 | $9,403,236 | $1,653,051 |
| Total Non Current Liabilities Net Minority Interest | $11,218,710 | $1,557,711 | $6,349,181 | $125,242 |
| Other Non Current Liabilities | $52,370 | $39,611 | $54,935 | $96,658 |
| Derivative Product Liabilities | $6,957,000 | $0 | - | - |
| Current Liabilities | $3,636,165 | $8,582,869 | $3,054,055 | $1,527,809 |
| Other Current Liabilities | $52,644 | $88,581 | $65,300 | $45,206 |
| Payables And Accrued Expenses | $2,224,987 | $1,919,325 | $1,499,513 | $882,281 |
| Payables | $1,830,124 | $1,419,044 | $1,149,983 | $537,644 |
| Accounts Payable | $1,830,124 | $1,419,044 | $1,137,823 | $510,758 |
| Total Tax Payable | - | $0 | $12,160 | $26,886 |
| Current Notes Payable | - | - | $0 | $141,298 |
| Equity | ||||
| Common Stock Equity | $5,869,302 | $2,304,422 | $18,352,589 | $15,242,519 |
| Total Equity Gross Minority Interest | $5,869,302 | $2,304,422 | $18,352,589 | $15,242,519 |
| Stockholders Equity | $5,869,302 | $2,304,422 | $18,352,589 | $15,242,519 |
| Other Equity Interest | $5,246,150 | $1,860,008 | $2,787,137 | $567,972 |
| Retained Earnings | $-145,826,144 | $-127,198,257 | $-108,381,629 | $-94,134,505 |
| Gains Losses Not Affecting Retained Earnings | - | - | - | - |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $5,861 | $5,861 | $5,861 | $5,861 |
| Ordinary Shares Number | $2,980,139 | $1,167,796 | $1,082,869 | $593,485 |
| Share Issued | $2,986,000 | $1,173,657 | $1,088,730 | $599,346 |
| Tangible Book Value | $5,734,388 | $2,238,504 | $18,352,589 | $15,239,225 |
| Invested Capital | $9,048,166 | $7,710,650 | $22,610,768 | $15,383,817 |
| Working Capital | $12,820,170 | $-560,419 | $20,123,925 | $12,603,682 |
| Capital Lease Obligations | $1,518,100 | $2,036,067 | $2,442,703 | $402,417 |
| Total Capitalization | $9,048,166 | $2,304,422 | $22,610,768 | $15,242,519 |
| Treasury Stock | $60,000 | $60,000 | $60,000 | $60,000 |
| Additional Paid In Capital | $146,449,576 | $127,679,198 | $123,985,306 | $108,857,065 |
| Capital Stock | $59,720 | $23,473 | $21,775 | $11,987 |
| Common Stock | $59,720 | $23,473 | $21,775 | $11,987 |
| Long Term Capital Lease Obligation | $1,030,476 | $1,518,100 | $2,036,067 | $28,584 |
| Current Capital Lease Obligation | $487,624 | $517,967 | $406,636 | $373,833 |
| Pensionand Other Post Retirement Benefit Plans Current | $870,910 | $650,768 | $1,082,606 | $85,191 |
| Current Accrued Expenses | $394,863 | $500,281 | $349,530 | $344,637 |
| Net PPE | $3,192,696 | $3,401,642 | $3,491,264 | $1,802,608 |
| Accumulated Depreciation | $-3,802,940 | $-3,740,769 | $-3,545,422 | $-3,217,319 |
| Gross PPE | $6,995,636 | $7,142,411 | $7,036,686 | $5,019,927 |
| Leases | $1,238,886 | $1,238,886 | $1,212,417 | $1,195,637 |
| Construction In Progress | $897,885 | $762,445 | $423,077 | $413,843 |
| Other Properties | $1,297,121 | $1,805,543 | $2,380,225 | $319,557 |
| Machinery Furniture Equipment | $3,561,744 | $3,335,537 | $3,020,967 | $3,090,890 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $2,413,186 | $754,830 | $170,191 | $91,772 |
| Work In Process | $1,266,542 | $982,630 | $128,993 | $100,453 |
| Raw Materials | $2,060,521 | $1,308,863 | $367,934 | $244,498 |
| Preferred Stock | - | - | - | - |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-19,320,663 | $-20,291,773 | $-11,424,463 | $-11,139,448 |
| Operating Activities | ||||
| Operating Cash Flow | $-18,690,565 | $-19,444,009 | $-11,280,546 | $-10,731,973 |
| Cash Flow From Continuing Operating Activities | $-18,690,565 | $-19,444,009 | $-11,280,546 | $-10,731,973 |
| Operating Gains Losses | $-1,171,350 | $676 | $47,538 | $2,285 |
| Investing Activities | ||||
| Capital Expenditure | $-630,098 | $-847,764 | $-143,917 | $-407,475 |
| Investing Cash Flow | $-630,098 | $-847,764 | $-143,917 | $-407,475 |
| Cash Flow From Continuing Investing Activities | $-630,098 | $-847,764 | $-143,917 | $-407,475 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $19,521,989 | $2,025,104 | $11,564,879 | $59,583 |
| Financing Cash Flow | $25,135,255 | $2,027,457 | $20,178,604 | $-681,645 |
| Cash Flow From Continuing Financing Activities | $25,135,255 | $2,027,457 | $20,178,604 | $-681,645 |
| Net Other Financing Charges | $-1,945,467 | $-60,753 | $-1,302,861 | $-232,845 |
| Net Common Stock Issuance | $19,521,989 | $2,025,104 | $11,564,879 | $59,583 |
| Common Stock Issuance | $19,521,989 | $2,025,104 | $11,564,879 | $59,583 |
| Other | ||||
| Repayment Of Debt | $-7,850,978 | $0 | $-626,533 | $-528,263 |
| Issuance Of Debt | $12,000,000 | $0 | $6,850,000 | $0 |
| Interest Paid Supplemental Data | $8,615 | $111,000 | $9,903 | $13,464 |
| Income Tax Paid Supplemental Data | $6,806 | $5,708 | $4,550 | $5,050 |
| End Cash Position | $9,266,353 | $3,451,761 | $21,716,077 | $12,961,936 |
| Beginning Cash Position | $3,451,761 | $21,716,077 | $12,961,936 | $24,783,029 |
| Changes In Cash | $5,814,592 | $-18,264,316 | $8,754,141 | $-11,821,093 |
| Proceeds From Stock Option Exercised | $3,409,711 | $63,106 | $3,693,119 | $19,880 |
| Net Issuance Payments Of Debt | $4,149,022 | $0 | $6,223,467 | $-528,263 |
| Net Long Term Debt Issuance | $4,149,022 | $0 | $6,223,467 | $-528,263 |
| Long Term Debt Payments | $-7,850,978 | $0 | $-626,533 | $-528,263 |
| Long Term Debt Issuance | $12,000,000 | $0 | $6,850,000 | $0 |
| Net Intangibles Purchase And Sale | $-105,091 | $-86,058 | $0 | - |
| Purchase Of Intangibles | $-105,091 | $-86,058 | $0 | - |
| Net PPE Purchase And Sale | $-525,007 | $-761,706 | $-143,917 | $-407,475 |
| Purchase Of PPE | $-525,007 | $-761,706 | $-143,917 | $-407,475 |
| Change In Working Capital | $-2,056,843 | $-3,136,778 | $1,227,392 | $-458,267 |
| Change In Other Current Liabilities | $-541,145 | $-443,204 | $-417,593 | $-446,527 |
| Change In Payables And Accrued Expense | $809,553 | $214,234 | $1,614,647 | $-81,837 |
| Change In Accrued Expense | $474,724 | $6,753 | $987,582 | $-147,073 |
| Change In Payable | $334,829 | $207,481 | $627,065 | $65,236 |
| Change In Account Payable | $334,829 | $207,481 | $627,065 | $65,236 |
| Change In Prepaid Assets | $496,902 | $-139,136 | $282,169 | $295,862 |
| Change In Inventory | $-2,693,926 | $-2,379,205 | $-230,395 | $-232,553 |
| Change In Receivables | $-128,227 | $-389,467 | $-21,436 | $6,788 |
| Changes In Account Receivables | $-128,227 | $-389,467 | $-21,436 | $6,788 |
| Other Non Cash Items | $1,524,914 | $1,192,574 | $107,963 | - |
| Stock Based Compensation | $790,145 | $444,147 | $675,700 | $224,939 |
| Depreciation Amortization Depletion | $850,456 | $872,000 | $907,985 | $889,140 |
| Depreciation And Amortization | $850,456 | $872,000 | $907,985 | $889,140 |
| Amortization Cash Flow | $46,175 | $20,140 | $3,294 | $21,799 |
| Amortization Of Intangibles | $46,175 | $20,140 | $3,294 | $21,799 |
| Depreciation | $804,281 | $851,860 | $904,691 | $867,341 |
| Gain Loss On Investment Securities | $-1,234,000 | - | - | - |
| Gain Loss On Sale Of PPE | $62,650 | $676 | $47,538 | $2,285 |
| Net Income From Continuing Operations | $-18,627,887 | $-18,816,628 | $-14,247,124 | $-11,394,170 |
| Provisionand Write Offof Assets | - | $8,000 | $0 | $4,100 |
| Change In Other Current Assets | - | - | - | $295,862 |
| Net Investment Purchase And Sale | - | - | - | - |
| Sale Of Investment | - | - | - | - |
| Amortization Of Securities | - | - | - | - |
Fetched: 2026-06-22